Clinical Genetic Testing for Familial Hypercholesterolemia (2018)
- Authors:
- Autor USP: SANTOS FILHO, RAUL DIAS DOS - FM
- Unidade: FM
- DOI: 10.1016/j.jacc.2018.05.044
- Subjects: HIPERCOLESTEROLEMIA; DOENÇAS CARDIOVASCULARES; COLESTEROL; CUSTOS DOS CUIDADOS DE SAÚDE
- Agências de fomento:
- Skylight Biotec
- Astellas
- Ono
- Boehringer Ingelheim
- Bayer
- Merck Sharp Dohme
- Kaneka Medics
- MSD
- Takeda
- Astellas Pharm
- Aegerion
- Japanese Circulation Society
- Japanese Ministry of Health, Labour and Welfare
- Japan Agency for Medical Research and Development
- Sanofi
- Ministry of Health of the Czech Republic [16-29084A, 15-28277A]
- New England Congenital Cardiology Research Foundation
- Pediatric Heart Network
- National Heart, Lung, and Blood Institute [HL059407]
- Alexion Pharma France SAS
- Language: Inglês
- Imprenta:
- Source:
- Título: Journal of the american college of cardiology
- ISSN: 0735-1097
- Volume/Número/Paginação/Ano: v. 72, n. 6, p. 662-680, 2018
- Status:
- Artigo possui versão em acesso aberto em repositório (Green Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
STURM, Amy C. e SANTOS, Raul D. Clinical Genetic Testing for Familial Hypercholesterolemia. Journal of the american college of cardiology, v. 72, n. 6, p. 662-680, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.jacc.2018.05.044. Acesso em: 15 abr. 2026. -
APA
Sturm, A. C., & Santos, R. D. (2018). Clinical Genetic Testing for Familial Hypercholesterolemia. Journal of the american college of cardiology, 72( 6), 662-680. doi:10.1016/j.jacc.2018.05.044 -
NLM
Sturm AC, Santos RD. Clinical Genetic Testing for Familial Hypercholesterolemia [Internet]. Journal of the american college of cardiology. 2018 ; 72( 6): 662-680.[citado 2026 abr. 15 ] Available from: https://doi.org/10.1016/j.jacc.2018.05.044 -
Vancouver
Sturm AC, Santos RD. Clinical Genetic Testing for Familial Hypercholesterolemia [Internet]. Journal of the american college of cardiology. 2018 ; 72( 6): 662-680.[citado 2026 abr. 15 ] Available from: https://doi.org/10.1016/j.jacc.2018.05.044 - Long-term efficacy and safety of mipomersen in patients with familial hypercholesterolaemia: 2-year interim results of an open-label extension
- Familial hypercholesterolaemia: PCSK9 inhibitors are coming [comentário]
- Relation of Hepatic Steatosis to Atherogenic Dyslipidemia
- Cigarette smoking worsens systemic inflammation in persons with metabolic syndrome
- Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation
- USPSTF recommendation on screening for lipid disorders in children and adolescents. [Carta]
- Down the rabbit hole: reviewing the evidence for primary prevention of cardiovascular disease in people with obesity
- Relation Between Self-Reported Physical Activity Level, Fitness, and Cardiometabolic Risk
- Global think tank on the clinical considerations and management of lipoprotein(a): The top questions and answers regarding what clinicians need to know
- The Role of Statins in Current Guidelines
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
